Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10767657 | Biochemical and Biophysical Research Communications | 2005 | 11 Pages |
Abstract
Nitric oxide-derived oxidants (e.g., peroxynitrite) are believed to participate in antimicrobial activities as part of normal host defenses but also in oxidative tissue injury in inflammatory disorders. A similar role is ascribed to the heme enzyme myeloperoxidase (MPO), the most abundant protein of polymorphonuclear leukocytes, which are the terminal phagocytosing effector cells of the innate immune system. Concomitant production of peroxynitrite and release of millimolar MPO are characteristic events during phagocytosis. In order to understand the mode of interaction between MPO and peroxynitrite, we have performed a comprehensive stopped-flow investigation of the reaction between all physiological relevant redox intermediates of MPO and peroxynitrite. Both iron(III) MPO and iron(II) MPO are rapidly converted to compound II by peroxynitrite in monophasic reactions with calculated rate constants of (6.8 ± 0.1) Ã 106 Mâ1 sâ1 and (1.3 ± 0.2) Ã 106 Mâ1 sâ1, respectively (pH 7.0 and 25 °C). Besides these one- and two-electron reduction reactions of peroxynitrite, which produce nitrogen dioxide and nitrite, a one-electron oxidation to the oxoperoxonitrogen radical must occur in the fast monophasic transition of compound I to compound II mediated by peroxynitrite at pH 7.0 [(7.6 ± 0.1) Ã 106 Mâ1 sâ1]. In addition, peroxynitrite induced a steady-state transition from compound III to compound II with a rate of (1.0 ± 0.3) Ã 104 Mâ1 sâ1. Thus, the interconversion among the various oxidation states of MPO that is prompted by peroxynitrite is remarkable. Reaction mechanisms are proposed and the physiological relevance is discussed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Paul Georg Furtmüller, Walter Jantschko, Martina Zederbauer, Manfred Schwanninger, Christa Jakopitsch, Susanna Herold, Willem H. Koppenol, Christian Obinger,